What is it about?
Analgesics commonly used to treat pediatric patients with malignancy patterned after the World Health Organization’s ‘analgesic ladder’ for cancer pain management
Featured Image
Why is it important?
Addressing pain management safely and effectively in pediatric patients with cancer will require advances in both drug development, to increase the armament of analgesics available for children, and our pharmacologic understanding of those analgesics in current use.
Perspectives
Advancing appropriate and adequate analgesic pharmacotherapy in pediatric patients with cancer is an area of clinical need.
Dr Catherine Sherwin
University of Utah
Read the Original
This page is a summary of: Pharmacokinetics, pharmacodynamics and pharmacogenetics associated with nonsteroidal anti-inflammatory drugs and opioids in pediatric cancer patients, Expert Opinion on Drug Metabolism & Toxicology, June 2017, Taylor & Francis,
DOI: 10.1080/17425255.2017.1329415.
You can read the full text:
Contributors
The following have contributed to this page
